Asthma Clinical Trial
Official title:
Improving Asthma Outcomes Through Spirometry Distance Learning
Spirometry is a recommended component of asthma diagnosis and treatment in the primary care
setting, yet few providers report its routine use for children with asthma.
Misclassification of asthma severity occurs when assessment is based on symptoms alone. This
misclassification can lead to inadequate treatment, increased morbidity, and increased
healthcare utilization/cost.
The goal of this study is to test the effectiveness of a distance learning quality
improvement program called Spirometry 360 developed by the interactive Medical Training
Resources (iMTR) group at the University of Washington Child Health Institute. The
Spirometry 360 program aims to improve care for children with asthma by enhancing provider
knowledge and self-efficacy related to the use and interpretation of office-based
spirometry.
| Status | Completed |
| Enrollment | 660 |
| Est. completion date | January 2012 |
| Est. primary completion date | January 2012 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Both |
| Age group | 5 Years to 17 Years |
| Eligibility |
Inclusion Criteria (Parent): - Parents must have a child who has had at least one visit for asthma with a participating provider during the 12 months before the study start date - Must have monthly access to email and the Internet - Must have child aged 5-16 years Inclusion Criteria (Child): - Aged 5-16 years - Must have access to email and the Internet Exclusion Criteria (Parents): - Parents with children who are outside our target age range of 5-16 years old - Parents with children who haven't had a clinic visit for asthma care in the last year - Parents without monthly access to the Internet Exclusion Criteria (Child): - Children who are outside our target age range of 5-16 years - Children without monthly access to email and the Internet |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Country | Name | City | State |
|---|---|---|---|
| United States | Slone Center Office-based Research Network (SCOR) - Boston University | Boston | Massachusetts |
| United States | Child Health Institute - Unversity of Washington | Seattle | Washington |
| United States | Puget Sound Pediatric Research Network | Seattle | Washington |
| United States | Seattle Children's Hospital Research Institute | Seattle | Washington |
| Lead Sponsor | Collaborator |
|---|---|
| Seattle Children's Hospital | Boston University, University of Washington |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Healthcare utilization | Parent report of number of Emergency Room/Emergency Department (ER/ED) visits, unplanned outpatient visits, and number of hospitalizations due to asthma in the last month. | Assessed monthly for 1 year | No |
| Primary | Cost of asthma care | Cost in inflation-adjusted dollars for unplanned healthcare utilization due to asthma exacerbation, including unplanned office visits, ED visits, and asthma-related hospitalization. | Every 6 months | No |
| Primary | Asthma-specific health-related quality of life | Parent report of child's asthma-specific health-related quality of life. Measured using )Pediatric Quality of Life Inventory (PedsQL)(TM) 3.0 Short Form (SF)-22 Asthma Module. The tool consists of an 11-item symptoms scale and an 11-item treatment problems scale. | Every 6 months | No |
| Secondary | Acceptable spirometry testing sessions | Monthly proportion of spirometry tests performed by enrolled practices with acceptable quality grades during intervention. | Assessed monthly for 1 year | No |
| Secondary | Appropriate prescription of controller therapy | Parent/child report asthma symptoms and unplanned health care utilization consistent with persistent/uncontrolled asthma AND patient has been prescribed a controller medication. | Assessed monthly for 1 year | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|